ISEE IVERIC bio Inc

Price (delayed)

$16.62

Market cap

$1.73B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.15

Enterprise value

$1.68B

IVERIC bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The Company is currently developing ...

Highlights
ISEE's EPS is up by 14% year-on-year
IVERIC bio's quick ratio has plunged by 69% YoY and by 28% from the previous quarter
IVERIC bio's net income has plunged by 64% YoY and by 12% from the previous quarter

Key stats

What are the main financial stats of ISEE
Market
Shares outstanding
104.01M
Market cap
$1.73B
Enterprise value
$1.68B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
10.75
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$107.82M
EBITDA
-$107.74M
Free cash flow
-$85.74M
Per share
EPS
-$1.15
Free cash flow per share
-$0.92
Book value per share
$1.55
Revenue per share
$0
TBVPS
$1.77
Balance sheet
Total assets
$165.67M
Total liabilities
$26.09M
Debt
$2.04M
Equity
$139.57M
Working capital
$138.7M
Liquidity
Debt to equity
0.01
Current ratio
6.55
Quick ratio
6.4
Net debt/EBITDA
0.45
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-53.6%
Return on equity
-60.5%
Return on invested capital
-96.3%
Return on capital employed
-76.6%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ISEE stock price

How has the IVERIC bio stock price performed over time
Intraday
1.59%
1 week
17.71%
1 month
78.52%
1 year
182.17%
YTD
140.52%
QTD
163.39%

Financial performance

How have IVERIC bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$108.06M
Net income
-$107.82M
Gross margin
N/A
Net margin
N/A
IVERIC bio's net income has plunged by 64% YoY and by 12% from the previous quarter
The operating income has plunged by 53% YoY and by 12% from the previous quarter

Growth

What is IVERIC bio's growth rate over time

Valuation

What is IVERIC bio stock price valuation
P/E
N/A
P/B
10.75
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ISEE's EPS is up by 14% year-on-year
The equity has decreased by 41% YoY and by 17% from the previous quarter

Efficiency

How efficient is IVERIC bio business performance
ISEE's return on equity is down by 27% since the previous quarter and by 27% year-on-year
ISEE's return on assets is down by 24% since the previous quarter and by 22% year-on-year
The ROIC has grown by 13% since the previous quarter

Dividends

What is ISEE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ISEE.

Financial health

How did IVERIC bio financials performed over time
IVERIC bio's total liabilities has surged by 119% YoY and by 29% QoQ
IVERIC bio's quick ratio has plunged by 69% YoY and by 28% from the previous quarter
The debt is 99% smaller than the equity
The equity has decreased by 41% YoY and by 17% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.